Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Schaeverbeke

Showing results (21-30 of 94) with videos related to

Pageof 10
Sort By:
Revue Du Rhumatisme (Ed. Francaise : 1993)|November 30, 1993
[Neutropenia after the first administration of methotrexate in rheumatoid arthritis]S Marcé, B Bannwarth, T Schaeverbeke, et al.
Clinical and Experimental Rheumatology|December 22, 2006
Development of type 1 diabetes mellitus in a patient with rheumatoid arthritis receiving anti-tumor necrosis factor alphaC Richez, P Blanco, H Gin, et al.
Annals of the Rheumatic Diseases|January 1, 1993
Where are peripheral analgesics acting?B Bannwarth, F Demotes-Mainard, T Schaeverbeke, et al.
Clinical and Experimental Rheumatology|November 27, 2008
Serum sickness following a first rituximab infusion with no recurrence after the second oneN Mehsen, C-M Yvon, C Richez, et al.
British Journal of Rheumatology|September 1, 1995
Is remitting seronegative symmetrical synovitis with pitting oedema (RS3PE syndrome) associated with HLA-A2?T Schaeverbeke, J P Vernhes, B Bannwarth, et al.
Revue Du Rhumatisme (English Ed.)|July 1, 1995
The facts about methotrexate in rheumatoid arthritisB Bannwarth, J P Vernhes, T Schaeverbeke, et al.
British Journal of Rheumatology|March 1, 1996
Hyper-IgM syndrome associated with rheumatoid arthritis: report of RA in a patient with primary impaired CD40 pathwayJ Sibilia, A Durandy, T Schaeverbeke, et al.
Presse Medicale (Paris, France : 1983)|February 20, 1993
[Generalized acute exanthematous pustulosis after ingestion of sulfasalazine]S Marce, T Schaeverbeke, B Bannwarth, et al.
Arthritis and Rheumatism|March 1, 1997
Reactive or septic arthritis? Comment on the article by Li et alT Schaeverbeke, C Bébéar, B Bannwarth, et al.
Neurology|April 27, 2005
Neuropathy resembling CIDP in patients receiving tumor necrosis factor-alpha blockersC Richez, P Blanco, A Lagueny, et al.
Pageof 10

Showing results (21-30 of 94) with videos related to

Sort By:
Pageof 10
Revue Du Rhumatisme (Ed. Francaise : 1993)|November 30, 1993
[Neutropenia after the first administration of methotrexate in rheumatoid arthritis]S Marcé, B Bannwarth, T Schaeverbeke, et al.
Clinical and Experimental Rheumatology|December 22, 2006
Development of type 1 diabetes mellitus in a patient with rheumatoid arthritis receiving anti-tumor necrosis factor alphaC Richez, P Blanco, H Gin, et al.
Annals of the Rheumatic Diseases|January 1, 1993
Where are peripheral analgesics acting?B Bannwarth, F Demotes-Mainard, T Schaeverbeke, et al.
Clinical and Experimental Rheumatology|November 27, 2008
Serum sickness following a first rituximab infusion with no recurrence after the second oneN Mehsen, C-M Yvon, C Richez, et al.
British Journal of Rheumatology|September 1, 1995
Is remitting seronegative symmetrical synovitis with pitting oedema (RS3PE syndrome) associated with HLA-A2?T Schaeverbeke, J P Vernhes, B Bannwarth, et al.
Revue Du Rhumatisme (English Ed.)|July 1, 1995
The facts about methotrexate in rheumatoid arthritisB Bannwarth, J P Vernhes, T Schaeverbeke, et al.
British Journal of Rheumatology|March 1, 1996
Hyper-IgM syndrome associated with rheumatoid arthritis: report of RA in a patient with primary impaired CD40 pathwayJ Sibilia, A Durandy, T Schaeverbeke, et al.
Presse Medicale (Paris, France : 1983)|February 20, 1993
[Generalized acute exanthematous pustulosis after ingestion of sulfasalazine]S Marce, T Schaeverbeke, B Bannwarth, et al.
Arthritis and Rheumatism|March 1, 1997
Reactive or septic arthritis? Comment on the article by Li et alT Schaeverbeke, C Bébéar, B Bannwarth, et al.
Neurology|April 27, 2005
Neuropathy resembling CIDP in patients receiving tumor necrosis factor-alpha blockersC Richez, P Blanco, A Lagueny, et al.
Pageof 10